Cholera toxin subunit B inhibits IL-12 and IFN-γ production and signaling in experimental colitis and Crohn's disease

Gut

Volumn 54, Issue 11, 2005, Pages 1558-1564

  Coccia, E M ^a   Remoli, M E ^a   Di Giacinto, C ^a   Del Zotto, B ^a   Giacomini, E ^a   Monteleone, G ^b   Boirivant, M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; GAMMA INTERFERON; INTERLEUKIN 12; STAT1 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; ENTEROPATHY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; EXPLANT; IN VITRO STUDY; INCUBATION TIME; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH1 CELL; WESTERN BLOTTING;

ADULT; ANIMALS; CELLS, CULTURED; CHOLERA TOXIN; COLITIS; CROHN DISEASE; DNA-BINDING PROTEINS; HUMANS; IMMUNITY, MUCOSAL; INTERFERON TYPE II; INTERLEUKIN-12; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED STRAINS; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PHOSPHORYLATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STAT4 TRANSCRIPTION FACTOR; TH1 CELLS; TRANS-ACTIVATORS;

EID: 27444438640     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.062174     Document Type: Article

References (42)

1. Podolsky D. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
2. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448-55.
3. Fais S, Capobianchi M, Pallone F, et al. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease: kinetics of in vitro response to interferon gamma inducers. Gut 1991;32:403-7.
4. Fuss I, Neurath M, Boirivant M, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157:1261-70.
5. Parronchi P, Romagnani P, Annunziato F, et al. Type 1 T-helper cell predominance and IL-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997;150:823-32.
6. Monteleone G, Biancone L, Marasco R, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997;112:1169-78.
7. Elson CO. Cholera toxin and its subunits as potential oral adjuvants. Curr Top Microbiol Immunol 1989;146:29-33.
8. Lycke N. The mechanism of cholera toxin adjuvanticity. Res Immunol 1997;148:504-20.
9. Williams N, Stasiuk L, Nashar T, et al. Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A 1997;94:5290-5.
10. Sobel D, Yankelevich B, Goyal D, et al. The B-subunit of cholera toxin induces immunoregulatory cells ana prevents diabetes in the NOD mouse. Diabetes 1998;47:186-91.
11. Boirivant M, Fuss IJ, Ferroni L, et al. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis. J Immunol 2001;166:3522-32.
12. Rengarajan J, Szabo S, Glimcher L. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000;21:479-83.
13. Leonard W. STATs and cytokine specificity. Nat Med 1996;2:968-9.
14. Agnello D, Iankford C, Bream J, et al. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Cli Immunol 2003;23:147-61.
15. Grogan J, Mohrs M, Harmon B, et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 2001;14:205-15.
16. Szabo S, Sullivan B, Peng S, et al. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 2003;21:713-58.
17. O'Shea J. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 1997;7:1-11.
18. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13:715-25.
19. Szabo S, Kim S, Costa G, et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000;100:655-69.
20. Kurata H, Lee H, O'Garra A, et al. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 1999;11:677-88.
21. Lebens M, Johansson S, Osek J, et al. Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines. Biotechnology 1993;11:1574-8.
22. Heijden PVd, Stok W. Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine. J Immunol Methods 1987;103:161-7.
23. Remoli ME, Giacomini E, Lutfalla G, et al. Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J Immunol 2002;169:366-74.
24. Bull DM, Bookman MA. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest 1977;59:966-74.
25. Quaranta M, Camponeschi B, Straface E, et al. Induction of interleukin-15 production by HIV-1 nef protein: a role in the proliferation of uninfected cells. Exp Cell Res 1999;250:112-21.
26. Nishikomori R, Usui T, Wu C, et al. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J Immunol 2002;169:4388-98.
27. Thierfelder W, Deursen Jv, Yamamoto K, et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996;382:171-4.
28. Neurath M, Weigmann B, Finotto S, et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 2002;195:1129-43.
29. Boirivant M, Fuss IJ, Chu A, et al. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998;188:1929-39.
30. Parrello T, Monteleone G, Cucchiara S, et al. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J Immunol 2000;165:7234-9.
31. Heath VL, Kurata H, Lee HJ, et al. Checkpoints in the regulation of T helper 1 responses. Curr Top Microbiol Immunol 2002;266:23-39.
32. Neurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity. Nat Med 2002;8:567-73.
33. Matsuoka K, Inoue N, Sato T, et al. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut 2004;53:1303-8.
34. Lavelle EC, McNeela E, Armstrong ME, et al. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J Immunol 2003;171:2384-92.
35. Sun J, Xiao B, Lindblad M, et al. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression. Int Immunol 2000;12:1449-57.
36. Parton RG. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 1994;42:155-66.
37. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-72.
38. Aman AT, Fraser S, Merritt EA, et al. A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity. Proc Natl Acad Sci U S A 2001;98:8536-41.
39. Wang M, Bregenholt S, Petersen JS. The cholera toxin B subunit directly costimulates antigen-primed CD4+ T cells ex vivo. Scand J Immunol 2003;58:342-9.
40. Yankelevich B, Soldatenkov VA, Hodgson J, et al. Differential induction of programmed cell death in CD8+ and CD4+ T cells by the B subunit of cholera toxin. Cell Immunol 1996;168:229-34.
41. Mudter J, Neurath MF. The role of signal transducers and activators of transcription in T inflammatory bowel diseases. Inflamm Bowel Dis 2003;9:332-7.
42. Mannon PJ, Fuss IJ, Mayer L, et al. Anti-interleukin-12 antibody for active crohn's disease. N Engl J Med 2004;351:2069-79.